~~<i id='96CDB0C280'><strike id='96CDB0C280'><tt id='96CDB0C280'><pre id='96CDB0C280'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：comprehensive 2025-09-29 19:38:15 Page View：65

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Charles Manson follower Leslie Van Houten released from prison after 53 years
Next article： Peter Hotez and the public health issue of online harassment

focus

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

STAT Executive Editor Rick Berke on STAT's 8th birthday

PhotosfromSTAT'sfirstyearofpublishinglaidoutforanedit.AlissaAmbrose/STATTodaySTATturns8.Intheseannua

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

Living with Fabry disease, a condition that causes chronic pain

JackJohnsonwasdiagnosedwithFabrydiseaseatage7.Photoillustration:CaseySheneryforSTATForJackJohnson,ge